Feasibility and Safety of Tethered Capsule Endomicroscopy in Patients With Barrett's Esophagus in a Multi-Center Study.
Barrett’s Esophagus
Optical Coherence Tomography
Tethered Capsule Endomicroscopy
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
08
01
2021
accepted:
02
02
2021
pubmed:
8
2
2021
medline:
17
3
2022
entrez:
7
2
2021
Statut:
ppublish
Résumé
Tethered capsule endomicroscopy (TCE) involves swallowing a small tethered pill that implements optical coherence tomography (OCT) imaging, procuring high resolution images of the whole esophagus. Here, we demonstrate and evaluate the feasibility and safety of TCE and a portable OCT imaging system in patients with Barrett's esophagus (BE) in a multi-center (5-site) clinical study. Untreated patients with BE as per endoscopic biopsy diagnosis were eligible to participate in the study. TCE procedures were performed in unsedated patients by either doctors or nurses. After the capsule was swallowed, the device continuously obtained 10-μm-resolution cross-sectional images as it traversed the esophagus. Following imaging, the device was withdrawn through mouth, and disinfected for subsequent reuse. BE lengths were compared to endoscopy findings when available. OCT-TCE images were compared to volumetric laser endomicroscopy (VLE) images from a patient who had undergone VLE on the same day as TCE. 147 patients with BE were enrolled across all sites. 116 swallowed the capsule (79%), 95/114 (83.3%) men and 21/33 (63.6%) women (P = .01). High-quality OCT images were obtained in 104/111 swallowers (93.7%) who completed the procedure. The average imaging duration was 5.55 ± 1.92 minutes. The mean length of esophagus imaged per patient was 21.69 ± 5.90 cm. A blinded comparison of maximum extent of BE measured by OCT-TCE and EGD showed a strong correlation (r = 0.77-0.79). OCT-TCE images were of similar quality to those obtained by OCT-VLE. The capabilities of TCE to be used across multiple sites, be administered to unsedated patients by either physicians or nurses who are not expert in OCT-TCE, and to rapidly and safely evaluate the microscopic structure of the esophagus make it an emerging tool for screening and surveillance of BE patients. Clinical trial registry website and trial number: NCT02994693 and NCT03459339.
Sections du résumé
BACKGROUND & AIMS
Tethered capsule endomicroscopy (TCE) involves swallowing a small tethered pill that implements optical coherence tomography (OCT) imaging, procuring high resolution images of the whole esophagus. Here, we demonstrate and evaluate the feasibility and safety of TCE and a portable OCT imaging system in patients with Barrett's esophagus (BE) in a multi-center (5-site) clinical study.
METHODS
Untreated patients with BE as per endoscopic biopsy diagnosis were eligible to participate in the study. TCE procedures were performed in unsedated patients by either doctors or nurses. After the capsule was swallowed, the device continuously obtained 10-μm-resolution cross-sectional images as it traversed the esophagus. Following imaging, the device was withdrawn through mouth, and disinfected for subsequent reuse. BE lengths were compared to endoscopy findings when available. OCT-TCE images were compared to volumetric laser endomicroscopy (VLE) images from a patient who had undergone VLE on the same day as TCE.
RESULTS
147 patients with BE were enrolled across all sites. 116 swallowed the capsule (79%), 95/114 (83.3%) men and 21/33 (63.6%) women (P = .01). High-quality OCT images were obtained in 104/111 swallowers (93.7%) who completed the procedure. The average imaging duration was 5.55 ± 1.92 minutes. The mean length of esophagus imaged per patient was 21.69 ± 5.90 cm. A blinded comparison of maximum extent of BE measured by OCT-TCE and EGD showed a strong correlation (r = 0.77-0.79). OCT-TCE images were of similar quality to those obtained by OCT-VLE.
CONCLUSIONS
The capabilities of TCE to be used across multiple sites, be administered to unsedated patients by either physicians or nurses who are not expert in OCT-TCE, and to rapidly and safely evaluate the microscopic structure of the esophagus make it an emerging tool for screening and surveillance of BE patients. Clinical trial registry website and trial number: NCT02994693 and NCT03459339.
Identifiants
pubmed: 33549871
pii: S1542-3565(21)00109-9
doi: 10.1016/j.cgh.2021.02.008
pmc: PMC8715859
mid: NIHMS1707174
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT03459339', 'NCT02994693']
Types de publication
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
756-765.e3Subventions
Organisme : NCI NIH HHS
ID : R01 CA184102
Pays : United States
Informations de copyright
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Références
Gut. 2013 Jan;62(1):15-21
pubmed: 22315471
Clin Gastroenterol Hepatol. 2008 Feb;6(2):159-64
pubmed: 18096439
Gastrointest Endosc. 2007 Oct;66(4):639-49
pubmed: 17643437
Gastrointest Endosc. 2018 Nov;88(5):830-840.e3
pubmed: 30031805
Gastrointest Endosc. 2007 Jan;65(1):50-6
pubmed: 17137858
Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51
pubmed: 26526079
Science. 1991 Nov 22;254(5035):1178-81
pubmed: 1957169
Gastrointest Endosc. 2015 Oct;82(4):631-40
pubmed: 25956472
Gastrointest Endosc. 2016 Jan;83(1):80-8
pubmed: 26124075
Gastrointest Endosc. 2018 Jul;88(1):35-42
pubmed: 29410080
Gastrointest Endosc. 2017 Nov;86(5):839-846
pubmed: 28322771
Can J Gastroenterol. 2008 Mar;22(3):243-6
pubmed: 18354752
Gastrointest Endosc. 2017 Sep;86(3):464-472
pubmed: 28161451
Gut. 2018 Nov;67(11):1942-1949
pubmed: 29084829
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Diagn Ther Endosc. 2012;2012:271914
pubmed: 23024577
Gastrointest Endosc. 2008 Oct;68(4):745-53
pubmed: 18926183
J Biomed Opt. 2016 Oct 1;21(10):104001
pubmed: 27689919
Biomed Opt Express. 2016 Jan 08;7(2):409-19
pubmed: 26977350
Gastrointest Endosc. 2008 Jul;68(1):25-31
pubmed: 18499107
Clin Gastroenterol Hepatol. 2006 Jan;4(1):38-43
pubmed: 16431303
Aliment Pharmacol Ther. 2004 Nov 15;20(10):1083-9
pubmed: 15569110
Nat Med. 2013 Feb;19(2):238-40
pubmed: 23314056
Am J Gastroenterol. 2020 Aug;115(8):1201-1209
pubmed: 32558685
Gastroenterology. 2013 Oct;145(4):723-5
pubmed: 23932950
Gastrointest Endosc. 2021 Apr;93(4):871-879
pubmed: 32735947
Lancet. 2020 Aug 1;396(10247):333-344
pubmed: 32738955
Gastrointest Endosc. 2016 May;83(5):880-888.e2
pubmed: 26344884
Sci Transl Med. 2018 Jan 17;10(424):
pubmed: 29343623
Gut. 2014 Jan;63(1):7-42
pubmed: 24165758
Gastroenterology. 2001 Jan;120(1):7-12
pubmed: 11208708
Am J Gastroenterol. 2014 Feb;109(2):298-9
pubmed: 24496431
Clin Gastroenterol Hepatol. 2021 Jun;19(6):1160-1169.e2
pubmed: 32434069
Gastroenterology. 2008 Jul;135(1):24-31
pubmed: 18442484
Aliment Pharmacol Ther. 2010 Mar;31(5):548-52
pubmed: 20002025
PLoS Med. 2015 Jan 29;12(1):e1001780
pubmed: 25634542
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1562-70.e1-2
pubmed: 23851020
Am J Gastroenterol. 2018 Aug;113(8):1156-1166
pubmed: 29891853
Biomed Opt Express. 2019 Feb 12;10(3):1207-1222
pubmed: 30891340
Biomed Opt Express. 2015 Mar 05;6(4):1146-63
pubmed: 25909001
Am J Gastroenterol. 2016 Nov;111(11):1664-1666
pubmed: 27808130